Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Pier Egisto Valensin"'
Publikováno v:
Università degli Studi di Siena-IRIS
To evaluate the impact of highly active antiretroviral therapy (HAART) on the course of hepatitis C (HCV) infection, we studied the biological and virological characteristics of 23 HCV/HIV-coinfected HAART-naive patients. The HCV genotype, HCV and HI
Autor:
Giulietta Venturi, Caroline Reid, Federico Dal Bello, Cristina Parolin, Maurizio Zazzi, Pier Egisto Valensin, Giorgio Palù, Laura Romano, Robert W. Shafer
Publikováno v:
Journal of Antimicrobial Chemotherapy. 53:356-360
Objectives: To compare three methods for using HIV-1 genotype to predict antiretroviral drug susceptibility. Methods: We applied three genotypic interpretation algorithms to 478 reverse transcriptase (RT) and 410 protease sequences for which phenotyp
Publikováno v:
Università degli Studi di Siena-IRIS
Acute meningitis is the most common neurologic disease that involves the central nervous system. The spectrum of infectious agents that cause neurologic infection is remarkably broad and numerous viruses are the most frequent cause of the aseptic men
Autor:
Rinaldo Zurbriggen, Reinhard Glück, Marco Donati, Peter Durrer, Marcello Valassina, Silvia Bianchi, Maria Grazia Cusi, Pier Egisto Valensin
Publikováno v:
Università degli Studi di Siena-IRIS
To improve the efficiency of liposome-mediated DNA transfer as a tool for gene therapy or vaccinology, we have further developed a new delivery system based on the modified immunopotentiating reconstituted influenza virus (IRIV). In this study, we en
Autor:
Rebecca Ferruzzi, Giulietta Venturi, Pier Egisto Valensin, M. Catucci, Maurizio Zazzi, Laura Romano
Publikováno v:
Journal of Virological Methods. 87:91-97
An ultrasensitive version of an 'in-house' reverse transcription-competitive polymerase chain reaction assay described previously for quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in plasma was developed. The increase in sensitivity
Publikováno v:
Università degli Studi di Siena-IRIS
Great variability in the course of human immunodeficiency virus type 1 (HIV-1) infection results from a complex interplay between host and virus factors. Some of the patients with prolonged nonprogressive infection have been reported to harbor virus
Autor:
Pier Egisto Valensin, Francesco Lauria, Giulia Scalia, Monica Tozzi, Donatella Moschettini, Daniele Laszlo, Piero Galieni, D. Donati
Publikováno v:
Journal of Medical Virology. 60:39-42
After primary infection in early life, human herpesvirus 6 (HHV-6) remains latent in the body and may reactivate in subjects with poor immune status. A 180-day longitudinal study of HHV-6 infection was carried out in 23 autologous bone marrow transpl
Autor:
Pier Egisto Valensin, Danielle Venditti, Marcello Valassina, Daniele Corsaro, Alain Le Faou, Véronique Venard
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 35:105-108
A duplex polymerase chain reaction (PCR) was developed for the simultaneous detection of Chlamydia pneumoniae and Mycoplasma pneumoniae . A study of 163 respiratory specimens from in-patients of the "Centre Hospitalier et Universitaire de Nancy" show
Autor:
M. Rubino, Laura Romano, M. Catucci, Maurizio Zazzi, Maria Letizia Riccio, A. Gonnelli, Giulietta Venturi, A. De Milito, Pier Egisto Valensin
Publikováno v:
ResearcherID
Karolinska Institutet
Karolinska Institutet
To define factors predictive of failure to respond to nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type-1 (HIV-1)-infected subjects pretreated with zidovudine (ZDV), three groups of subjects shifted to double therapy wi
Autor:
Marco R. Oggioni, Maurizio Zazzi, Francesca Peruzzi, Gianni Pozzi, Fabrizio Manca, Donata Medaglini, Pier Egisto Valensin, Luisa Bracci, Tiziana Maggi, Luisa Lozzi, Laura Romano
Publikováno v:
AIDS Research and Human Retroviruses. 15:451-459
Five different V3 domains of HIV-1 gp120 were expressed on the surface of the gram-positive bacterium Streptococcus gordonii, a model live vector for vaccine delivery. Sera of HIV-1-infected individuals and human monoclonal antibodies specifically re